Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Viking Therapeutics: Strong Results In Obesity
Article By:
MoneyShow.com
Saturday, April 13, 2024 5:17 PM EDT
With a potential best in class drug for oral and injectable use, Viking Therapeutics has to be on many Big Pharma/Bio acquisition wish lists, as the company represents a very scarce asset in the $100 billion market for weight loss drugs.
2 Top Biotech Buyout Candidates
Article By:
Andrew Rocco
Sunday, March 31, 2024 4:00 PM EDT
Investors who are adventurous, have a high-risk tolerance, and are home run hitters may opt for biotech stocks. Investors in this group may want to hone in on stocks that have the potential to be bought out. Here are some top buyout candidates.
DexCom: A Winner In Diabetes Management
Article By:
MoneyShow.com
Sunday, February 25, 2024 1:00 PM EDT
Diabetes management and glucose monitoring solutions provider DexCom, Inc. recently released its fourth-quarter results, reporting $1.0 billion in revenue, up 27% year-over-year compared to $820 million a year ago. Can it go even higher?